USPTO 2015–2025 USPTO PatentsView US Corporation

Baxter International Inc.

USPTO PatentsView assignee record - 620 granted patents across 93 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Baxter ranks #734 of 49,997 tracked US assignees by granted-patent volume, with 620 patents across 93 technology areas.

#734
of 49,997 US assignees by volume
Top 1%
by Innovation Score (65.0/100)
18.7
avg claims per patent
-11%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R734 · US Corporation #734 · 620 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MID 620 grants
  • TOP-DECILE #734/49,997
  • PHOTO-FINISH Siemens Energy…
  • CPC-WIDE A61M · 93 areas
  • INNOV-STRONG 65.0/100
  • CLAIMS-RICH 18.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -11% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Siemens Energy Global GmbH & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Baxter

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Baxter's Innovation Score is 65.0/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Baxter's grant cadence moved

Between 2020–2024, Baxter International Inc. received 271 grants versus 305 in 2015–2019 (-11% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2015 at 92 grants and bottomed in 2018 at 45. Lead class A61M accounts for 64.8% of the portfolio across 93 subclasses. Volume neighbours: Siemens Medical Solutions USA, Inc. (#730) and Institut National de la Sante et de la Recherche Medicale (INSERM) (#738).

Baxter's three-year grant acceleration

From 2019–2021 to 2022–2024, Baxter International Inc. moved from 168 to 167 grants (0.99x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,202. See the growth leaderboard.

Who files at Baxter's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Baxter holds 620 patents at rank #734, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Baxter

By rank, the assignees closest to #734 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Baxter's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Baxter, neither rank-band nor same-CPC leaders (those blocks stay above).

Baxter's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

65 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

406080100 20152016201720182019202020212022202320242025 44
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Baxter International Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 92 14.8%
2016 56 9.0%
2017 48 7.7%
2018 45 7.3%
2019 64 10.3%
2020 52 8.4%
2021 52 8.4%
2022 51 8.2%
2023 53 8.5%
2024 63 10.2%
2025partial year 44 7.1%

Which technologies does Baxter International Inc. patent most?

Top 15 of 93 technology areas

Where it ranks

Overall rank by patents

#734

of 49,997 tracked assignees

Innovation Score

65.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Baxter International Inc.'s patent record in context - here's where to go next.

  • Baxter International Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 64.8% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #734 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Baxter International Inc. against Siemens Medical Solutions USA, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 65.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.